Flare Therapeutics

Based in Cambridge, MA, Flare Therapeutics is a biotechnology company opening up a new therapeutic space with a novel approach to decipher the biology of transcription factors to develop small molecule medicines. Based on insights from the seminal work of its scientific founders, Flares team has uncovered switch sites, druggable regions that are key targets for transcription factor regulation to address mutations that cause disease. The company was founded in 2021.